Praxis Precision Medicines Inc (PRAX)
45.27
+0.06
(+0.13%)
USD |
NASDAQ |
May 17, 16:00
45.27
0.00 (0.00%)
After-Hours: 20:00
Praxis Precision Medicines Cash from Operations (Quarterly): -20.86M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -20.86M |
| December 31, 2023 | -23.86M |
| September 30, 2023 | -23.22M |
| June 30, 2023 | -31.21M |
| March 31, 2023 | -32.85M |
| December 31, 2022 | -28.81M |
| September 30, 2022 | -44.92M |
| June 30, 2022 | -57.21M |
| March 31, 2022 | -54.11M |
| Date | Value |
|---|---|
| December 31, 2021 | -44.86M |
| September 30, 2021 | -23.96M |
| June 30, 2021 | -30.01M |
| March 31, 2021 | -25.72M |
| December 31, 2020 | -20.23M |
| September 30, 2020 | -13.88M |
| June 30, 2020 | -9.944M |
| March 31, 2020 | -8.569M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-57.21M
Minimum
Jun 2022
-8.569M
Maximum
Mar 2020
-29.07M
Average
-25.72M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 31.92M |
| Regeneron Pharmaceuticals Inc | 1.512B |
| Atossa Therapeutics Inc | -4.698M |
| ADMA Biologics Inc | -2.218M |
| Viking Therapeutics Inc | -6.134M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -91.22M |
| Cash from Financing (Quarterly) | 182.76M |
| Free Cash Flow | -99.15M |
| Free Cash Flow Per Share (Quarterly) | -1.50 |
| Free Cash Flow to Equity (Quarterly) | -20.86M |
| Free Cash Flow Yield | -23.82% |